These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 17714119)
1. Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity. Schmid-Wendtner MH; Korting HC J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1013-8. PubMed ID: 17714119 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. Gupta AK; Gregurek-Novak T Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230 [TBL] [Abstract][Full Text] [Related]
3. The new oral antifungal agents for onychomycosis of the toenails. Gupta AK; Shear NH J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624 [TBL] [Abstract][Full Text] [Related]
4. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Gupta AK; Ryder JE; Johnson AM Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339 [TBL] [Abstract][Full Text] [Related]
5. The systemic treatment of onychomycosis. Wenig JA Clin Podiatr Med Surg; 1995 Apr; 12(2):263-74. PubMed ID: 7600500 [TBL] [Abstract][Full Text] [Related]
6. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients. Ginter-Hanselmayer G; Weger W; Smolle J J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238 [TBL] [Abstract][Full Text] [Related]
7. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents. Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639 [TBL] [Abstract][Full Text] [Related]
8. The systemic treatment of onychomycosis. Wenig JA Clin Podiatr Med Surg; 2004 Oct; 21(4):579-89, vi. PubMed ID: 15450898 [TBL] [Abstract][Full Text] [Related]
9. Current trends in onychomycosis therapy: a literature review. Hecker D Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835 [TBL] [Abstract][Full Text] [Related]
10. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis. Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272 [TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis. Gupta AK Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650 [TBL] [Abstract][Full Text] [Related]
12. Toenail onychomycosis: current and future treatment options. Finch JJ; Warshaw EM Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258 [TBL] [Abstract][Full Text] [Related]
14. The use of systemic antimycotics in dermatotherapy. Niewerth M; Korting HC Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319 [TBL] [Abstract][Full Text] [Related]
15. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus. Gupta AK; Gover MD; Lynde CW J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029 [TBL] [Abstract][Full Text] [Related]
16. Management of onychomycosis in children. Gupta AK; De Rosso JQ Postgrad Med; 1999 Jul; Spec No():31-7. PubMed ID: 10492664 [TBL] [Abstract][Full Text] [Related]